VEGFA and COVID-19: LNPs are clinically approved RNA transport vehicles and are currently used for the transport of COVID‐19 mRNA vaccines manufactured by Pfizer‐BioNTech and Moderna.[40, 41] In the current study, we used one of the clinically approved LNPs (MC3‐LNPs) to deliver different mRNA molecules, including mRNA encoding VEGF‐A protein, in vitro and in vivo.